Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRE
726
DELISTED
Duke Realty Corp.
DRE
| $16.1M | 0.03% |
869,027
+457,250
| +111% | +$9.07M |
|
|
WLB
727
DELISTED
Westmoreland Coal Company
WLB
| $16.1M | 0.03% |
774,161
-47,778
| -6% | -$1.27M |
|
|
SBNY
728
DELISTED
Signature Bank
SBNY
| $16.1M | 0.03% |
109,727
+100,465
| +1,085% | +$14M |
|
729
TransUnion
TRU
$16.3B
| $16M | 0.03% |
+638,598
| New | +$15.9M |
|
|
ADVM
730
DELISTED
Adverum Biotechnologies
ADVM
| $16M | 0.03% |
98,488
+88,052
| +844% | +$29.7M |
|
731
Sony
SONY
$142B
| $16M | 0.03% |
2,816,485
+1,722,960
| +158% | +$10.6M |
|
732
Eversource Energy
ES
$26.8B
| $16M | 0.03% |
351,552
+322,596
| +1,114% | +$15.6M |
|
733
Jazz Pharmaceuticals
JAZZ
$16.5B
| $15.8M | 0.03% |
89,809
+26,214
| +41% | +$4.71M |
|
734
Telephone and Data Systems
TDS
$3.81B
| $15.8M | 0.03% |
537,571
-156,077
| -23% | -$4.48M |
|
|
ITCI
735
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $15.8M | 0.03% |
+493,044
| New | +$12.5M |
|
736
Atmos Energy
ATO
$28.4B
| $15.7M | 0.03% |
+306,250
| New | +$16.4M |
|
737
Upbound Group
UPBD
$1.12B
| $15.6M | 0.03% |
+550,094
| New | +$16.5M |
|
|
MLNX
738
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $15.6M | 0.03% |
320,724
+93,724
| +41% | +$4.55M |
|
739
Lockheed Martin
LMT
$130B
| $15.6M | 0.03% |
+83,757
| New | +$16.1M |
|
740
Crown Holdings
CCK
$13B
| $15.6M | 0.03% |
294,007
+277,553
| +1,687% | +$15.3M |
|
741
Snap-on
SNA
$20.4B
| $15.5M | 0.03% |
97,031
-41,765
| -30% | -$6.44M |
|
|
PVA
742
DELISTED
PENN VIRGINIA CORP
PVA
| $15.5M | 0.03% |
3,527,531
+3,105,022
| +735% | +$17.6M |
|
|
MDR
743
DELISTED
McDermott International
MDR
| $15.4M | 0.03% |
+964,425
| New | +$15.1M |
|
|
RPAI
744
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $15.4M | 0.03% |
1,108,068
-774,835
| -41% | -$11.8M |
|
|
SPPI
745
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $15.4M | 0.03% |
2,249,229
+368,494
| +20% | +$2.34M |
|
|
WEB
746
DELISTED
Web.com Group, Inc.
WEB
| $15.4M | 0.03% |
634,532
+138,354
| +28% | +$3M |
|
747
Wabtec
WAB
$50.3B
| $15.4M | 0.03% |
+162,962
| New | +$16M |
|
748
CALL
Amgen
AMGN
$240B
| $15.4M | 0.03% |
+100,000
| New | +$16M |
|
749
W.R. Berkley
WRB
$25.9B
| $15.4M | 0.03% |
997,677
+725,672
| +267% | +$10.8M |
|
|
ATW
750
DELISTED
Atwood Oceanics
ATW
| $15.3M | 0.03% |
579,940
-824,361
| -59% | -$25.3M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.